DNTH vs HAS · rev $6.2M vs P/E 25, rev $4.75B
Dianthus Therapeutics Inc. (DNTH) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
DNTH currently screens at market cap $4.40B. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the DNTH and HAS stock pages for the full models.
Not investment advice.